Patents by Inventor Hongshan Zhang

Hongshan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9619952
    Abstract: Systems and methods are provided that include preventing access to users of an access control system, for example, by facilitating an administrator temporarily forbidding access by all users to one or more areas secured by one or more doors associated with one or more card readers. Some methods can include reading a first management card at a first card reader, identifying a first group of which the first card reader is a part, identifying a plurality of card readers in the first group, and updating a database device to indicate that access via the first card reader or any card reader in the plurality of card readers is forbidden.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: April 11, 2017
    Assignee: HONEYWELL INTERNATIONAL INC.
    Inventors: Liugang Zhao, Hongshan Zhang, Binbin Zhu
  • Patent number: 8487157
    Abstract: Transgenic rodents having NGF beta gene mutants in their genomes express NGF beta mutant proteins. The preparation methods of the transgenic rodents, the methods of utilizing the transgenic animals to prepare NGF beta mutant proteins and the resulting NGF beta mutant proteins are provided. The transgenic rodents are useful in preparing human NGF and in the study of the functions of NGF beta mutants and their receptors in the whole animal level, and also useful for screening and purifying NGF beta mutants which have high activity and high security.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: July 16, 2013
    Assignee: Staidson (Beijing) Pharmaceutical Co., Ltd.
    Inventors: Zhiwen Zhou, Hongshan Zhang, Hongbo Chen
  • Publication number: 20110082285
    Abstract: Transgenic rodents having NGF beta gene mutants in their genomes express NGF beta mutant proteins. The preparation methods of the transgenic rodents, the methods of utilizing the transgenic animals to prepare NGF beta mutant proteins and the resulting NGF beta mutant proteins are provided. The transgenic rodents are useful in preparing human NGF and in the study of the functions of NGF beta mutants and their receptors in the whole animal level, and also useful for screening and purifying NGF beta mutants which have high activity and high security.
    Type: Application
    Filed: March 7, 2008
    Publication date: April 7, 2011
    Applicant: STAIDSON (BEIJING) PHARMACEUTICAL CO., LTD
    Inventors: Zhiwen Zhou, Hongshan Zhang, Hongbo Chen